LYFIX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class I) is managed by Alpha Centric Fund with $33.4M in net assets. LYFIX expense ratio is 1.46%, holding 65 positions across sectors including Health Care, Unknown, Financials. Inception date: 2019-11-29.

LYFIX performance shows a YTD return of 4.05%. The 1-year return is 25.25% and the 5-year return is 5.88%. LYFIX dividend yield stands at 1.72%, paid annually.

LYFIX top holdings include Gilead Sciences Inc (7.9%), Nvaesrtex Pharmaceuticals Inc (6.0%), Developed Markets Astrazeneca Plc Sponsored Adr (5.3%), Insmed Inc Sedol 2614487 (4.1%), Ionis Pharmaceuticals Inc (4.0%). View all LYFIX holdings, sector breakdown, or dividend history.

LYFIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LYFIX alternatives are available via the screener, along with tax-loss harvesting opportunities.